Thursday, October 10, 2019 8:44:06 PM
Based on dollar value, regardless of sales, the current stock valuation is a big mistake and needs some adjusting....due to these, lets say, ASSETS...
"...the average cost to bring a low-to-moderate 510(k) product from concept to market is $31 million. More than 77 percent of that, $24 million, was spent on FDA-dependent or related activities. High-risk PMA costs averaged $94 million, with $75 million spent on FDA-linked stages, nearly 80 percent of the total cost of bringing devices to
market." (sourced from article "Medical device makers spend millions to meet FDA rules, study finds" in MEDCITY NEWS).
Qmed also confirms this...
"It takes about $24 million on average for each 510(k). That is the latest from a report led by Stanford University researcher Josh Makower, MD, and sponsored by the Medical Device Manufacturers Association (MDMA), the National Venture Capital Association (NVCA), and others. The study affixes an average price tag of $24 million to each successful 510(k) clearance in the United States
Depending on where you look, FDA Costs can go as high as 200 mil, 24 mil is a low number."
So we use the "low" 24 mil number...
So BIEL has FDA cleared knee and foot = 24 mil value.
So BIEL has FDA cleared post op = 24 mil value.
So BIEL working FDA cleared full body = 24 mil value.
So if we say "Biel's Market Cap is Only $17.6 Million Dollars" then,
where do the FDA clearance assets fit into the equation?
If you're a taxicab company with 100m worth of vehicles and city properties, wouldn't your company be valued higher than 100m?
Lingerie Fighting Championships Signs Broadcast Deal With Maybacks Global Entertainment • BOTY • Sep 26, 2024 9:00 AM
Maybacks Global Entertainment and Lingerie Fighting Championships Enter Into Broadcast And Revenue Sharing Agreement • AHRO • Sep 26, 2024 8:30 AM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM